Calls the 9/18 candle a test, not distribution — close held above the 200 SMA and essentially on the 50 SMA. Higher lows (325.63 > 314.69) plus a rising MACD off a −4.10 washout argue the coil resolves up, not down.
Backs the trader's full 1.25–1.5× cap and 50/25/25 tranches: half now, a quarter on a pullback to $335.77, the last quarter only on a confirmed close above $356 — waiting for a "clean" setup just means paying more later.
Agrees the fundamental direction is bullish but calls the first tranche too large going into an unconfirmed pivot — the 9/18 rejection is a real warning, not a verdict, and the sub-zero MACD crossover is "healing, not confirmed."
Proposes a 25–30% initial tranche near $344.41, another 25–30% in the $335–339 accumulation zone, and 25–40% only on a close above $356, capping total exposure at 1.0–1.25× rather than 1.5×.
Reads the 9/18 candle as textbook distribution — a high-volume reversal into resistance that deserves respect, not dismissal — and flags negative Q2 FCF, paused buybacks, and 5× debt growth in 18 months as real strain, not just AI-buildout optics.
Does not say avoid GOOG, but wants no more than 20–25% deployed at market, a hard cap at 1.0× standard allocation, and the largest tranche held back until a confirmed close above $356 proves the correction is over.
Thesis: The operating evidence won the debate — Q2 revenue of $119.8B grew 24.2% YoY on an accelerating curve, margins expanded from 30.5% to 36.1%, the balance sheet holds ~$130B net cash, and the single biggest overhang on the ad engine, antitrust, just produced a favorable ruling alongside new monetization vectors (external TPU sales, the closed Wiz acquisition, cloud strength). The bear's cash-flow punches are real but are timing arguments, not evidence of deterioration: Q2 FCF of −$5.9B reflects a deliberate, net-cash-funded AI buildout, and H1 FCF was still positive. But the forward 23.2x multiple is roughly fair, not cheap — the dataset's earnings bases (reported $19.94, normalized ~$10.10, forward $14.84) don't cleanly reconcile — and the 9/18 high-volume rejection at $355.13 on the heaviest volume since August, plus the paused buyback, argue against a full-size print.
Action: build toward only 1.0–1.25× a standard single-name allocation (hard cap) in three tranches — ~30% at market near $344.41, ~30% only if the $335–339 support cluster holds on daily closes, and the remaining ~40% only on a confirmed daily close above $356, which would break the descending-high series (398→375→355) and open $366–377, then the May highs near $398. Trim back to market weight on a daily close below $335.77 (the rising 200 SMA); exit entirely on a daily close below $314.69 (the July floor). Use close-based triggers given the ~8-point ATR — position size, not stop placement, is the real protection against a regulatory gap-down. Re-underwrite at the next checkpoint on Q3 operating cash flow vs. capex and any buyback resumption.